Advertisement
Regulations
Subscribe to Regulations

The Lead

TSRI Team Shows How Rare Antibody Targets Ebola, Marburg Viruses

February 27, 2015 1:20 pm | by Scripps Research Institute | News | Comments

Marburg virus is Ebola’s deadly cousin. The virus is up to 90 percent lethal—and doctors are desperate for tools to fight it. Read more...

Panel: Use New Meningitis Vaccines Only For Outbreaks

February 27, 2015 12:58 pm | by Mike Stobbe, AP Medical Writer - Associated Press | News | Comments

A federal panel on Thursday recommended that two new meningitis vaccines only be used for rare...

Takeda's Treatment for Acid-Related Diseases is Now Available in Japan

February 27, 2015 9:10 am | News | Comments

This medicine treats acid-related diseases with a novel mechanism of action called potassium-...

Watchdog Group Seeks FDA Ban of Antifungal Tablets

February 25, 2015 9:56 am | by Associated Press | News | Comments

A consumer safety group is calling on the Food and Drug Administration to pull certain...

View Sample

FREE Email Newsletter

Daily news and top headlines for drug research professionals

Takeda Acquires Select Portfolio from Neutec to Boost Business in Turkey

February 24, 2015 3:33 pm | News | Comments

The portfolio composed of 13 products in the gastroenterology, respiratory, metabolic and musculoskeletal therapeutic areas. Read more...

Liberia: 8 Hospital Staff Under Observation in Ebola Scare

February 23, 2015 4:25 pm | by Jonathan Paye-Layleh | News | Comments

Eight health workers at a hospital in Liberia's capital have been sent home for observation after coming into contact with a patient who later tested positive for Ebola, the country's assistant health minister said Saturday. Read more...

Improving Patient Onboarding with Advancements in Medical Device Training

February 23, 2015 10:48 am | by Craig Baker, Executive Vice President, Noble | Articles | Comments

For some patients diagnosed with chronic medical conditions, weekly or biweekly self-administration using drug delivery devices is often a necessary component of a successful treatment program. Read more...

Advertisement

7 Infected, 2 Dead After 'Superbug' Outbreak at Hospital

February 19, 2015 9:30 am | by Robert Jablon, Associated Press | News | Comments

Contaminated medical instruments are to blame for infecting seven patients - including two who died - with an antibiotic-resistant and potentially deadly "superbug" at Ronald Reagan UCLA Medical Center, hospital officials said. A total of 179 patients may be infected. Read more....

In Pakistan, Vaccinating Children Has Become a Deadly Battle

February 18, 2015 8:38 am | by Rebecca Santana, Associated Press | News | Comments

While vaccine distrust has sparked debates amid a measles outbreak in the United States, Pakistan is in a deadly battle to wipe out polio. Read more...                  

Amid Measles Outbreak, Few Rules on Teacher Vaccinations

February 17, 2015 11:53 am | by Christine Armario, Associated Press | News | Comments

While much of the attention in the ongoing measles outbreak has focused on student vaccination requirements and exemptions, less attention has been paid to another group in the nation's classrooms: Teachers and staff members, who, by and large, are not required to be vaccinated. Read more...

Researchers Test Device to Help Deaf Children Detect Sounds

February 13, 2015 4:48 pm | by Lauran Neergaard, AP Medical Writer | News | Comments

The device goes beyond cochlear implants that have brought hearing to many deaf children but that don't work for tots who lack their hearing nerve. Read more...                 

Closing the Knowledge Gap on Cancer Drug Toxicity

February 12, 2015 3:59 pm | by David Jackson, Ph.D., Chief Innovation Officer, MolecularHealth | Articles | Comments

There is a dangerous knowledge gap in the use of cancer medications that needs to be closed, immediately. Read more...                                                          

Advertisement

BioMed Realty Breaks Ground on Life Science Development

February 12, 2015 2:55 pm | News | Comments

​Joined by San Diego political leaders and representatives of the life science community, BioMed Realty Trust, Inc. broke ground on a new 316,000 square foot laboratory and office campus designed to meet the unique real estate needs of San Diego's thriving life science industry. Read more...

Commuter with Measles Prompts California Transit Warning

February 12, 2015 11:48 am | by Paul Elias, Associated Press | News | Comments

​Officials in Northern California on Wednesday warned Bay Area Rapid Transit commuters that they may have been exposed to measles after an infected LinkedIn employee used the trains. Read more...                 

Qiagen's Tuberculosis Treatment Preferred in Large Study

February 11, 2015 4:49 pm | News | Comments

Groundbreaking clinical data published in the The Lancet medical journal showed that reliance on the 100-year-old tuberculin skin test has significantly overestimated latent tuberculosis infections in China, while results in the same patients using the QuantiFERON-TB Gold (QFT) from QIAGEN N.V. provided a far better understanding of disease burden. Read more...

Redefining Chronic Fatigue with Better Diagnosis, New Name

February 11, 2015 10:25 am | by Lauren Neergaard, AP Medicial Writer - Associated Press | News | Comments

Doctors are getting a new way to diagnose chronic fatigue syndrome - and influential government advisers say it's time to replace that hated name, too, to show it's a real and debilitating disease. Read more...            

Supplements Industry Derides NY Attorney General's DNA Tests

February 9, 2015 11:32 am | by Mary Esch, Associated Press | News | Comments

DNA barcoding has exposed some infamous cases of food fraud, like cheap catfish sold as pricey grouper and expensive "sheep's milk" cheese that was really made from cow's milk. But can it tell if a pill touted as an energy-booster contains ginseng or is just a mix of rice powder and pine? Read more...

Advertisement

Hackers See Rewarding Targets in Health Care Companies

February 6, 2015 4:17 pm | by Tom Murphy and Brandon Bailey, AP Business Writers - Associated Press | News | Comments

Health care is a treasure trove for criminals looking to steal reams of personal information, as the hacking of a database maintained by the second-largest U.S. health insurer proves. Read more...                                      

Astellas Broadens Commitment to Clinical Trial Data Transparency

February 3, 2015 9:08 am | by Astellas | News | Comments

Astellas Pharma Inc. announced that the company will now make trial data available through www.clinicalstudydatarequest.com, an independent Web site that enables researchers to request and access clinical trial data after approval of a research proposal by an independent review panel. Read more...

Obama's Budget Targets High Cost of Cutting-Edge Drugs

February 2, 2015 10:11 pm | by Ricardo Alonso-Zaldivar, Associated Press | News | Comments

With patients facing greater exposure to the high cost of new medications, President Barack Obama on Monday called for government to use its buying power to squeeze drug companies for lower prices. Read more..            

Complex Incentives Drive Macular Degeneration Prescription Decisions

February 2, 2015 10:06 pm | by Stanford University | News | Comments

Two drugs that treat macular degeneration are practically interchangeable - except for the price. Ranibizumab costs up to $2,000 per dose, while bevacizumab is $50 per dose. Researchers at the Stanford University School of Medicine suspected that doctors treating Medicare patients would have a financial incentive to prescribe a more costly drug. Read more...

GOP's Christie: Parents Should Have Choice in Vaccinations

February 2, 2015 10:31 am | by Jill Colvin, Associated Press | News | Comments

New Jersey Gov. Chris Christie, a likely Republican candidate for president, said Monday that parents should have some choice on whether to vaccinate their children. Read more..                

Arizona Monitoring Hundreds for Measles Linked to Disneyland

January 29, 2015 10:03 am | by Felicia Fonseca, Associated Press | News | Comments

A measles outbreak in Arizona that originated at California's Disney parks is at risk of increasing dramatically in size as health officials keep tabs on 1,000 people, including nearly 200 children who could have been exposed at a Phoenix-area medical center.

U.S. Measles Outbreak Hits 87 Cases and Counting

January 28, 2015 12:33 pm | by Stephanie Guzowski, Editor | Articles | Comments

The measles outbreak, which originated at Disneyland, continues to expand, with 87 confirmed cases in people ranging in ages from 7 months to 70 years. Read more...                                     

Mylan Expands Hepatitis C Licensing Agreement with Gilead

January 26, 2015 11:18 am | by Associated Press | News | Comments

 Mylan Inc. announced that its subsidiary Mylan Laboratories Limited is expanding its hepatitis C licensing agreement with Gilead Sciences, Inc. to include the non-exclusive rights to manufacture and distribute the investigational NS5A inhibitor GS-5816 and single tablet regimen of sofosbuvir(Sovaldi)/GS-5816, once approved, in 91 developing countries. Read more...

Added Protections for Consumer Info on Health Website

January 26, 2015 9:56 am | by Associated Press | News | Comments

The Obama administration appears to be making broader changes to protect consumer information on the government's health insurance website, after objections from lawmakers and privacy advocates. Read more...                 

Medical Pot Only OK for Sick Kids Failed by Other Drugs: MDS

January 26, 2015 9:52 am | by Lindsey Tanner, AP Medical Writer - Associated Press | News | Comments

With virtually no hard proof that medical marijuana benefits sick children, and evidence that it may harm developing brains, the drug should only be used for severely ill kids who have no other treatment option, the nation's most influential pediatricians group says in a new policy. Read more...

Aetna Picks Gilead Sciences Hepatitis C Drugs Over Abbvie's

January 20, 2015 12:01 pm | by Associated Press | News | Comments

Insurer Aetna has made new hepatitis C drugs from Gilead Sciences Inc. preferred treatments for customers with the liver-destroying virus. Read more...                                    

Container Closure Integrity: Testing at Low Temps

January 20, 2015 11:10 am | by Louis Brasten, Supervisor, Routine and Functional Analysis/Filling Services, Barbara Jacobs, Scientist, Analytical Services, Alicia Brydzinski, Scientist, Analytical Services - West Pharmaceutical Services, Inc. | Articles | Comments

The container closure integrity, or CCI, on packaging for parenteral drug products plays a critical role in the preservation of the drug product. The combination of the packaging closure components must be carefully selected to eliminate means of contamination that could affect the drug product negatively. Read more...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading